These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3696326)

  • 41. Hereditary nephropathy with hematuria (Alport's syndrome).
    Chiricosta A; Jindal SL; Metuzals J; Koch B
    Can Med Assoc J; 1970 Feb; 102(4):396-401. PubMed ID: 4905862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal transplant in patients with Alport's syndrome.
    Byrne MC; Budisavljevic MN; Fan Z; Self SE; Ploth DW
    Am J Kidney Dis; 2002 Apr; 39(4):769-75. PubMed ID: 11920343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary excretion of hydroxyproline and hydroxylysyl glycosides in adjuvant-induced arthritis.
    Orloff S; Rao VH; Verbruggen L
    Ital J Biochem; 1979; 28(3):173-82. PubMed ID: 553901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-performance liquid chromatographic method for measuring hydroxylysine glycosides and their ratio in urine as a possible marker of human bone collagen breakdown.
    Grazioli V; Casari E; Murone M; Bonini PA
    J Chromatogr; 1993 May; 615(1):59-66. PubMed ID: 8340463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre-column derivatization and its optimum conditions for quantitative determination of urinary hydroxylysine glycosides by high-performance liquid chromatography.
    Yoshihara K; Mochidome N; Shida Y; Hayakawa Y; Nagata M
    Biol Pharm Bull; 1993 Jun; 16(6):604-7. PubMed ID: 8364515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
    Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
    Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Alport's syndrome: hereditary nephropathy with hematuria and deafness].
    Giger C; Guignard JP; Pelet B; Campiche M; Krstic R
    Rev Med Suisse Romande; 1988 Apr; 108(4):349-55. PubMed ID: 3387770
    [No Abstract]   [Full Text] [Related]  

  • 48. [Alport-Perkoff's syndrome (two cases report)].
    Prieto Veiga J; Rosado T; Blázquez García J; Martín García M; De Manueles Jiménez J; Escribano Albarrán R; Salazar A-Villalobos V
    An Esp Pediatr; 1977 Feb; 10(2):187-96. PubMed ID: 869343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alport's syndrome: experience at Hôpital Necker.
    Habib R; Gubler MC; Hinglais N; Noël LH; Droz D; Levy M; Mahieu P; Foidart JM; Perrin D; Bois E; Grünfeld JP
    Kidney Int Suppl; 1982 May; 11():S20-8. PubMed ID: 6956772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survey on heredity nephropathies (special reference to Alport's syndrome).
    Uraoka Y; Akano N; Tooda M; Iseki T; Miyamoto H; Maki S
    Nihon Jinzo Gakkai Shi; 1983 Sep; 25(9):1115-25. PubMed ID: 6663892
    [No Abstract]   [Full Text] [Related]  

  • 51. Urinary excretion of hydroxylysyl glycosides during acute inflammation in the rat.
    Askenasi R; Le Lous M; Rao VH; Bazin S
    Clin Sci Mol Med; 1976 Mar; 50(3):195-7. PubMed ID: 1253529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent allograft antiglomerular basement membrane glomerulonephritis in a patient with Alport's syndrome.
    Rassoul Z; al-Khader AA; al-Sulaiman M; Dhar JM; Coode P
    Am J Nephrol; 1990; 10(1):73-6. PubMed ID: 2188508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Determination of hydroxylysine glycosides in urine using an amino acid analyzer].
    Daĭkhin EI; Zamaraeva TV; Mazhuga NA; Kuznetsov LV
    Lab Delo; 1985; (10):592-4. PubMed ID: 2416992
    [No Abstract]   [Full Text] [Related]  

  • 54. No association between Alport's syndrome and antithyroid antibodies.
    Lambert M; Pirson Y; De Nayer P; van Ypersele de Strihou C
    Nephrol Dial Transplant; 1992; 7(11):1082-4. PubMed ID: 1336133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linear glomerular IgG fixation in renal allografts: incidence and significance in Alport's syndrome.
    Quérin S; Noël LH; Grünfeld JP; Droz D; Mahieu P; Berger J; Kreis H
    Clin Nephrol; 1986 Mar; 25(3):134-40. PubMed ID: 3514017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-glomerular and anti-tubular basement membrane nephritis in a renal allograft recipient with Alport's syndrome.
    Diaz JI; Valenzuela R; Gephardt G; Novick A; Tubbs RR
    Arch Pathol Lab Med; 1994 Jul; 118(7):728-31. PubMed ID: 8024409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary excretion of O-hydroxylysylglycosides in diabetes mellitus.
    Sato T; Saito T; Kokubun M; Ito M; Inoue M; Saito K; Yoshinaga K
    Tohoku J Exp Med; 1980 May; 131(1):97-8. PubMed ID: 7404578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishing the diagnosis of benign familial hematuria. The importance of examining the urine sediment of family members.
    Blumenthal SS; Fritsche C; Lemann J
    JAMA; 1988 Apr; 259(15):2263-6. PubMed ID: 3352118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Alport's syndrome].
    Schröder CH; Monnens LA; Veerkamp JH; Brunner HG
    Ned Tijdschr Geneeskd; 1988 Feb; 132(7):289-93. PubMed ID: 3347302
    [No Abstract]   [Full Text] [Related]  

  • 60. A rapid and simple method for quantitation of urinary hydroxylysyl glycosides, indicators of collagen turnover, using liquid chromatography/tandem mass spectrometry.
    Casetta B; Romanello M; Moro L
    Rapid Commun Mass Spectrom; 2000; 14(23):2238-41. PubMed ID: 11114034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.